Keyphrases
Acute Heart Failure
13%
Adipocyte Progenitor Cells
6%
All-cause Mortality
15%
Ambulatory Heart Failure
5%
Atrial Fibrillation
5%
Body Mass Index
8%
Cardiac Function
6%
Cardiac Regeneration
7%
Cardiogenic Shock
6%
Cardiovascular Disease
6%
Cardiovascular Mortality
9%
Cell Therapy
5%
Chronic Heart Failure
16%
Confidence Interval
12%
Epicardial Adipose Tissue
9%
Estimated Glomerular Filtration Rate
6%
European Society of Cardiology
5%
Extracellular Vesicles
5%
Hazard Ratio
10%
Heart Failure
64%
Heart Failure Hospitalization
8%
Heart Failure Patients
17%
Heart Failure with Preserved Ejection Fraction (HFpEF)
17%
High-sensitivity Troponin T
7%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
6%
Left Ventricular Ejection Fraction
21%
Multivariable
5%
Myocardial Infarction
23%
Myocardium
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
18%
Natriuretic Peptides
5%
Neprilysin
7%
Patients with Heart Failure
31%
Prognostic Value
13%
Quality of Life
5%
Risk Stratification
11%
Soluble Suppression of Tumorigenicity 2 (sST2)
9%
ST-elevation Myocardial Infarction (STEMI)
18%
Medicine and Dentistry
Acute Decompensated Heart Failure
9%
Acute Heart Infarction
5%
Adipose Tissue
15%
Amino Terminal Sequence
9%
Atrial Fibrillation
5%
Biological Marker
17%
Body Mass Index
5%
Brain Natriuretic Peptide
8%
Cardiac Magnetic Resonance Imaging
6%
Cardiogenic Shock
7%
Cardiology
6%
Cardiovascular Disease
7%
Cardiovascular System
14%
Cell Therapy
6%
Congestive Heart Failure
87%
Cord Blood
6%
Dilated Cardiomyopathy
7%
Diseases
7%
Ejection Fraction
12%
Glomerular Filtration Rate
5%
Hazard Ratio
8%
Heart Failure with Preserved Ejection Fraction
8%
Heart Failure with Reduced Ejection Fraction
7%
Heart Function
5%
Heart Left Ventricle Ejection Fraction
18%
Heart Muscle Ischemia
5%
Heart Ventricle Remodeling
6%
Infarction
8%
Interatrial Block
6%
Mesenchymal Stem Cell
9%
Myocardial Infarction
21%
Myocardium
9%
Outpatient
6%
Progenitor Cell
9%
Risk Stratification
9%
ST Segment Elevation Myocardial Infarction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
10%
Acute Heart Infarction
6%
All Cause Mortality
9%
Biological Marker
26%
Brain Natriuretic Peptide
12%
Cardiovascular Disease
6%
Cause of Death
5%
Clinical Trial
7%
Congestive Heart Failure
100%
Disease
5%
Heart Failure with Reduced Ejection Fraction
8%
Heart Infarction
26%
Heart Ventricle Remodeling
7%
Infarction
10%
Inflammation
5%
Membrane Metalloendopeptidase
9%
Non Insulin Dependent Diabetes Mellitus
7%
Pig
5%
ST Segment Elevation Myocardial Infarction
12%
Troponin T
9%
Valsartan/Sacubitril
5%
